{"id":"https://openalex.org/W4390960950","doi":"https://doi.org/10.3310/hta13500","title":"Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY) - A pharmacoepidemiological and qualitative study","display_name":"Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY) - A pharmacoepidemiological and qualitative study","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W4390960950","doi":"https://doi.org/10.3310/hta13500"},"language":"en","primary_location":{"id":"pmh:oai:discovery.dundee.ac.uk:openaire/d5dcedaa-ab9d-4ce8-8708-61b2c66e9c81","doi":null,"is_oa":true,"landing_page_url":"https://discovery.dundee.ac.uk/en/publications/d5dcedaa-ab9d-4ce8-8708-61b2c66e9c81","pdf_url":null,"source":{"id":"https://openalex.org/S4306400523","display_name":"Discovery Research Portal (University of Dundee)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177639307","host_organization_name":"University of Dundee","host_organization_lineage":["https://openalex.org/I177639307"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Wong, I C K, Asherson, P, Bilbow, A, Clifford, S, Coghill, D, DeSoysa, R, Hollis, C, McCarthy, S, Murray, M, Planner, C, Potts, L, Sayal, K & Taylor, E 2009, 'Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY) - pharmacoepidemiological and qualitative study', Health Technology Assessment, vol. 13, no. 50, pp. 1-144. < http://www.hta.ac.uk/1513 >","raw_type":"info:eu-repo/semantics/publishedVersion"},"volume":null,"type":"article","indexed_in":["doaj"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://discovery.dundee.ac.uk/en/publications/d5dcedaa-ab9d-4ce8-8708-61b2c66e9c81","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079729727","display_name":"Ian Chi Kei Wong","orcid":"https://orcid.org/0000-0001-8242-0014","observed_orcids":["https://orcid.org/0000-0001-8242-0014"]},"institutions":[{"id":"https://openalex.org/I124357947","display_name":"University of London","ror":"https://ror.org/04cw6st05","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947"]},{"id":"https://openalex.org/I4405283614","display_name":"UCL School of Pharmacy","ror":"https://ror.org/01zna6t55","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I4405283614","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Wong, I. C. K.","raw_affiliation_strings":["Centre for Paediatric Pharmacy Research, School of Pharmacy, University of London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Paediatric Pharmacy Research, School of Pharmacy, University of London, London, UK","institution_ids":["https://openalex.org/I124357947","https://openalex.org/I4405283614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017195801","display_name":"Philip J. Asherson","orcid":"https://orcid.org/0000-0003-2667-2254","observed_orcids":["https://orcid.org/0000-0003-2667-2254"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Asherson, P.","raw_affiliation_strings":["MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068144862","display_name":"Andrea Bilbow","orcid":"https://orcid.org/0000-0002-1888-4049","observed_orcids":["https://orcid.org/0000-0002-1888-4049"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bilbow, A.","raw_affiliation_strings":["ADDISS, Edgware, Middlesex, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ADDISS, Edgware, Middlesex, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5141702871","display_name":"S Clifford","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I124357947","display_name":"University of London","ror":"https://ror.org/04cw6st05","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947"]},{"id":"https://openalex.org/I4405283614","display_name":"UCL School of Pharmacy","ror":"https://ror.org/01zna6t55","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I4405283614","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Clifford, S.","raw_affiliation_strings":["Centre for Paediatric Pharmacy Research, School of Pharmacy, University of London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Paediatric Pharmacy Research, School of Pharmacy, University of London, London, UK","institution_ids":["https://openalex.org/I124357947","https://openalex.org/I4405283614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5141552738","display_name":"D Coghill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Coghill, D.","raw_affiliation_strings":["Section of Psychiatry, University of Dundee, Dundee, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Psychiatry, University of Dundee, Dundee, UK","institution_ids":["https://openalex.org/I177639307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033217061","display_name":"R DeSoysa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"DeSoysa, R.","raw_affiliation_strings":["Royal Liverpool Children\u2019s NHS Trust, Alder Hey, Liverpool, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Liverpool Children\u2019s NHS Trust, Alder Hey, Liverpool, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013162603","display_name":"Chris P. Hollis","orcid":"https://orcid.org/0000-0003-1083-6744","observed_orcids":["https://orcid.org/0000-0003-1083-6744"]},"institutions":[{"id":"https://openalex.org/I4210137227","display_name":"Queen's Medical Centre","ror":"https://ror.org/03ap6wx93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468","https://openalex.org/I4210137227"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Hollis, C.","raw_affiliation_strings":["Division of Psychiatry, Queen\u2019s Medical Centre, Nottingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Psychiatry, Queen\u2019s Medical Centre, Nottingham, UK","institution_ids":["https://openalex.org/I4210137227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056372208","display_name":"Suzanne McCarthy","orcid":"https://orcid.org/0000-0002-0695-7052","observed_orcids":["https://orcid.org/0000-0002-0695-7052"]},"institutions":[{"id":"https://openalex.org/I124357947","display_name":"University of London","ror":"https://ror.org/04cw6st05","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947"]},{"id":"https://openalex.org/I4405283614","display_name":"UCL School of Pharmacy","ror":"https://ror.org/01zna6t55","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I4405283614","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"McCarthy, S.","raw_affiliation_strings":["Centre for Paediatric Pharmacy Research, School of Pharmacy, University of London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Paediatric Pharmacy Research, School of Pharmacy, University of London, London, UK","institution_ids":["https://openalex.org/I124357947","https://openalex.org/I4405283614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063549953","display_name":"Macey L. Murray","orcid":"https://orcid.org/0000-0001-6418-0854","observed_orcids":["https://orcid.org/0000-0001-6418-0854"]},"institutions":[{"id":"https://openalex.org/I124357947","display_name":"University of London","ror":"https://ror.org/04cw6st05","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947"]},{"id":"https://openalex.org/I4405283614","display_name":"UCL School of Pharmacy","ror":"https://ror.org/01zna6t55","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I4405283614","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Murray, M.","raw_affiliation_strings":["Centre for Paediatric Pharmacy Research, School of Pharmacy, University of London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Paediatric Pharmacy Research, School of Pharmacy, University of London, London, UK","institution_ids":["https://openalex.org/I124357947","https://openalex.org/I4405283614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003532734","display_name":"Claire Planner","orcid":"https://orcid.org/0000-0003-0938-0444","observed_orcids":["https://orcid.org/0000-0003-0938-0444"]},"institutions":[{"id":"https://openalex.org/I124357947","display_name":"University of London","ror":"https://ror.org/04cw6st05","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947"]},{"id":"https://openalex.org/I4405283614","display_name":"UCL School of Pharmacy","ror":"https://ror.org/01zna6t55","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I4405283614","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Planner, C.","raw_affiliation_strings":["Centre for Paediatric Pharmacy Research, School of Pharmacy, University of London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Paediatric Pharmacy Research, School of Pharmacy, University of London, London, UK","institution_ids":["https://openalex.org/I124357947","https://openalex.org/I4405283614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112681002","display_name":"Laura C. Potts","orcid":"https://orcid.org/0000-0002-2935-6532","observed_orcids":["https://orcid.org/0000-0002-2935-6532"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Potts, L.","raw_affiliation_strings":["Mental Health and Neuroscience Clinical Trial Unit, Institute of Psychiatry, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mental Health and Neuroscience Clinical Trial Unit, Institute of Psychiatry, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079604448","display_name":"Kapil S. Sayal","orcid":"https://orcid.org/0000-0002-2050-4316","observed_orcids":["https://orcid.org/0000-0002-2050-4316"]},"institutions":[{"id":"https://openalex.org/I4210137227","display_name":"Queen's Medical Centre","ror":"https://ror.org/03ap6wx93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468","https://openalex.org/I4210137227"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sayal, K.","raw_affiliation_strings":["Division of Psychiatry, Queen\u2019s Medical Centre, Nottingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Psychiatry, Queen\u2019s Medical Centre, Nottingham, UK","institution_ids":["https://openalex.org/I4210137227"]}]},{"author_position":"last","author":{"id":null,"display_name":"Taylor, E.","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Taylor, E.","raw_affiliation_strings":["Department of Child and Adolescent Psychiatry, Institute of Psychiatry, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Child and Adolescent Psychiatry, Institute of Psychiatry, London, UK","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4768,"has_fulltext":true,"cited_by_count":51,"citation_normalized_percentile":{"value":0.81898128,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.9990000128746033},{"id":"https://openalex.org/keywords/adhd-medication","display_name":"ADHD medication","score":0.7210000157356262},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.7940000295639038},{"id":"https://openalex.org/keywords/methylphenidate","display_name":"methylphenidate","score":0.8629999756813049},{"id":"https://openalex.org/keywords/d-amphetamine","display_name":"d-amphetamine","score":0.9950000047683716},{"id":"https://openalex.org/keywords/atomoxetine","display_name":"atomoxetine","score":1.0},{"id":"https://openalex.org/keywords/youth","display_name":"youth","score":0.5339999794960022},{"id":"https://openalex.org/keywords/medication-persistence","display_name":"treatment persistence","score":0.48100000619888306},{"id":"https://openalex.org/keywords/reasons-for-treatment-discontinuation","display_name":"reasons for treatment discontinuation","score":0.6570000052452087},{"id":"https://openalex.org/keywords/patient-perspectives","display_name":"patient perspectives","score":0.4259999990463257},{"id":"https://openalex.org/keywords/primary-care-prescribing","display_name":"primary care prescribing","score":0.46799999475479126},{"id":"https://openalex.org/keywords/child-and-adolescent-mental-health-services","display_name":"child and adolescent mental health services","score":0.7250000238418579},{"id":"https://openalex.org/keywords/adult-mental-health-services","display_name":"adult mental health services","score":0.5649999976158142},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.35199999809265137},{"id":"https://openalex.org/keywords/psychiatric-comorbidity","display_name":"psychiatric comorbidity","score":0.41100001335144043}],"concepts":[{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.5769719481468201},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.536700427532196},{"id":"https://openalex.org/C190248442","wikidata":"https://www.wikidata.org/wiki/Q839486","display_name":"Qualitative research","level":2,"score":0.5063818693161011},{"id":"https://openalex.org/C2994409691","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit disorder","level":2,"score":0.4589660167694092},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43990030884742737},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3956170678138733},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.08703556656837463},{"id":"https://openalex.org/C36289849","wikidata":"https://www.wikidata.org/wiki/Q34749","display_name":"Social science","level":1,"score":0.08543598651885986}],"mesh":[],"locations_count":5,"locations":[{"id":"pmh:oai:discovery.dundee.ac.uk:openaire/d5dcedaa-ab9d-4ce8-8708-61b2c66e9c81","doi":null,"is_oa":true,"landing_page_url":"https://discovery.dundee.ac.uk/en/publications/d5dcedaa-ab9d-4ce8-8708-61b2c66e9c81","pdf_url":null,"source":{"id":"https://openalex.org/S4306400523","display_name":"Discovery Research Portal (University of Dundee)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177639307","host_organization_name":"University of Dundee","host_organization_lineage":["https://openalex.org/I177639307"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Wong, I C K, Asherson, P, Bilbow, A, Clifford, S, Coghill, D, DeSoysa, R, Hollis, C, McCarthy, S, Murray, M, Planner, C, Potts, L, Sayal, K & Taylor, E 2009, 'Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY) - pharmacoepidemiological and qualitative study', Health Technology Assessment, vol. 13, no. 50, pp. 1-144. < http://www.hta.ac.uk/1513 >","raw_type":"info:eu-repo/semantics/publishedVersion"},{"id":"pmh:oai:doaj.org/article:4d9e780009f54451b6f868139f539a1c","doi":"https://doi.org/10.3310/hta13500","is_oa":true,"landing_page_url":"https://doaj.org/article/4d9e780009f54451b6f868139f539a1c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Health Technology Assessment, Vol 13, Iss 50 (2009)","raw_type":"article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1350402","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/1350402/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"HEALTH TECHNOLOGY ASSESSMENT , 13 (50) 1-+. (2009)","raw_type":"Article"},{"id":"pmh:oai:hub.hku.hk:10722/171392","doi":"https://doi.org/10.3310/hta13500","is_oa":false,"landing_page_url":"http://hdl.handle.net/10722/171392","pdf_url":null,"source":{"id":"https://openalex.org/S4377196271","display_name":"The HKU Scholars Hub (University of Hong Kong)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I889458895","host_organization_name":"University of Hong Kong","host_organization_lineage":["https://openalex.org/I889458895"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/9795bd88-9960-4722-ae3c-3330155eca96","doi":"https://doi.org/10.3310/hta13500","is_oa":false,"landing_page_url":"https://www.scopus.com/pages/publications/73449121930","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Wong, I C K, Asherson, P, Bilbow, A, Clifford, S, Coghill, D, DeSoysa, R, Hollis, C, McCarthy, S, Murray, M, Planner, C, Potts, L, Sayal, K & Taylor, E 2009, 'Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY) - : A pharmacoepidemiological and qualitative study', Health Technology Assessment, vol. 13, no. 50, pp. 1-120. https://doi.org/10.3310/hta13500","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:discovery.dundee.ac.uk:openaire/d5dcedaa-ab9d-4ce8-8708-61b2c66e9c81","doi":null,"is_oa":true,"landing_page_url":"https://discovery.dundee.ac.uk/en/publications/d5dcedaa-ab9d-4ce8-8708-61b2c66e9c81","pdf_url":null,"source":{"id":"https://openalex.org/S4306400523","display_name":"Discovery Research Portal (University of Dundee)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177639307","host_organization_name":"University of Dundee","host_organization_lineage":["https://openalex.org/I177639307"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Wong, I C K, Asherson, P, Bilbow, A, Clifford, S, Coghill, D, DeSoysa, R, Hollis, C, McCarthy, S, Murray, M, Planner, C, Potts, L, Sayal, K & Taylor, E 2009, 'Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY) - pharmacoepidemiological and qualitative study', Health Technology Assessment, vol. 13, no. 50, pp. 1-144. < http://www.hta.ac.uk/1513 >","raw_type":"info:eu-repo/semantics/publishedVersion"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320337846","display_name":"UCB Pharma","ror":"https://ror.org/01n029866"},{"id":"https://openalex.org/F4320338413","display_name":"Cilag","ror":"https://ror.org/02fe4h741"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W608820535","https://openalex.org/W2610277301","https://openalex.org/W2781616133","https://openalex.org/W2561202861","https://openalex.org/W2961687523","https://openalex.org/W2929697852","https://openalex.org/W4366524864","https://openalex.org/W1566344982","https://openalex.org/W1495142838","https://openalex.org/W2569015834"],"abstract_inverted_index":{"Objectives:":[0],"To":[1],"estimate":[2,21],"the":[3,22,27,85,99,138,169,213,226,259,266,294,317,324,361,375,383,393,399,404,415,419,424,435,443,461,478,495,501,516,540,547,565],"prevalence":[4,231,257,295,517],"of":[5,24,42,73,90,164,181,215,225,232,319,327,329,343,351,363,395,418,422,439,480,503,518,564,602],"attention":[6],"deficit":[7],"hyperactivity":[8],"disorder":[9],"(ADHD)":[10],"pharmacological":[11],"treatment,":[12],"and":[13,16,19,34,52,71,88,108,114,118,127,144,158,189,204,209,340,386,475,505,600],"its":[14,506],"demographic":[15],"clinical":[17],"details,":[18],"to":[20,83,247,286,306,372,430,454,463,465,522,531],"proportion":[23],"patients":[25,132,173,244,251,261,283,290,303,310,352,431,441,469,523],"in":[26,123,168,212,245,252,256,258,265,270,284,291,296,304,311,333,410,414,535,544,554,574],"target":[28],"group":[29],"who":[30,366],"stopped":[31,358],"ADHD":[32,74,182,219,413,525,559],"treatment":[33,91,214,320,354,359,368,379,488,550,576,591],"investigate":[35,84],"possible":[36],"factors":[37],"for":[38,153,198,398,482,494],"continuation":[39],"or":[40,156,196],"cessation":[41,72,321,490],"treatment.":[43],"Design:":[44],"A":[45],"pharmacoepidemiological":[46,63],"study":[47,55,64,82,139,275,402,513,566],"using":[48,56,98],"an":[49,79,492],"automated":[50],"database":[51],"a":[53,62,179,186,274,437],"qualititative":[54],"patient":[57],"interviews.":[58],"Part":[59,76,94,105,130,171,175,229,381,400,511,562],"1":[60,162,176,201,512],"was":[61,78,262,335,390,428,537],"that":[65,316,348,447,515,549,568],"provided":[66],"accurate":[67],"data":[68,166],"on":[69,487,508],"use":[70],"drugs.":[75],"2":[77,401,563],"in-depth":[80],"interview":[81],"reasons,":[86],"processes":[87],"outcomes":[89],"cessation.":[92,380],"Setting:":[93],"1:":[95,131,230],"primary":[96],"care":[97,110],"General":[100],"Practice":[101],"Research":[102],"Database":[103],"(GPRD).":[104],"2:":[106,172,382],"secondary":[107],"tertiary":[109],"paediatric":[111,580],"clinics,":[112],"child":[113],"adolescent":[115,205,425],"mental":[116,120],"health":[117,121],"adult":[119,207],"clinics":[122],"London,":[124],"Nottingham,":[125],"Dundee":[126],"Liverpool.":[128],"Participants:":[129],"were":[133,220,369,498],"15-21":[134],"years":[135,342],"old":[136],"during":[137],"period":[140],"(1":[141],"January":[142],"2001":[143],"31":[145],"December":[146],"2004),":[147],"had":[148,159,178,190,357,470,572],"at":[149,160,199],"least":[150,161,200],"one":[151],"prescription":[152,277],"methylphenidate,":[154,194],"dexamfetamine":[155,195],"atomoxetine":[157,197],"year":[163,377],"research-standard":[165],"available":[167],"GPRD.":[170],"fulfilled":[174],"criteria,":[177],"diagnosis":[180],"as":[183,223,392,491],"detected":[184],"by":[185,520],"predefined":[187],"algorithm":[188],"been":[191,408],"treated":[192],"with":[193,218,412,473,524,592],"year.":[202],"Child":[203,384],"psychiatrists,":[206],"psychiatrists":[208],"paediatricians":[210],"involved":[211],"young":[216,450,483,556,570],"people":[217,451],"also":[221],"interviewed":[222],"part":[224],"study.":[227],"Results:":[228],"prescribing":[233,334,519,536],"averaged":[234],"across":[235],"all":[236],"ages":[237],"increased":[238,278],"eightfold,":[239],"from":[240,279,299,528,579],"0.26":[241],"per":[242,249,281,288,301,308],"1000":[243,250,282,289,302,309],"1999":[246,285,305],"2.07":[248],"2006.":[253,312],"The":[254,331,533],"increase":[255],"younger":[260],"less":[263],"evident":[264],"older":[267],"patients.":[268],"Prevalence":[269],"15-year-old":[271],"males":[272],"receiving":[273],"drug":[276],"1.32":[280],"8.31":[287],"2006,":[292],"whereas":[293],"21-yearolds":[297],"rose":[298],"0":[300],"0.43":[307],"Survival":[313],"analysis":[314,346],"showed":[315,347,446],"rate":[318,326],"largely":[322],"exceeded":[323],"estimated":[325],"persistence":[328],"ADHD.":[330],"reduction":[332],"most":[336],"noticeable":[337],"between":[338],"16":[339],"17":[341],"age.":[344],"Kaplan-Meier":[345],"approximately":[349],"18%":[350],"restarted":[353,367],"if":[355],"they":[356],"after":[360,432,456,577],"age":[362,420,529],"15.":[364],"Patients":[365,485],"more":[370],"likely":[371],"restart":[373,464],"within":[374],"first":[376],"following":[378],"Health":[385],"Illness":[387],"Profile":[388],"(CHIP)":[389],"chosen":[391],"quality":[394],"life":[396],"questionnaire":[397],"because":[403],"CHIP-CE":[405],"scale":[406],"has":[407],"validated":[409],"children":[411],"UK.":[416],"Because":[417],"range":[421],"participants,":[423],"version":[426],"(CHIP-AE)":[427],"administered":[429],"interview.":[433],"Of":[434],"15,":[436],"total":[438],"nine":[440],"finished":[442],"questionnaire.":[444],"Interviews":[445],"although":[448],"some":[449,555,569],"felt":[452,460],"able":[453],"cope":[455],"stopping":[457,504],"medication,":[458],"others":[459],"need":[462],"control":[466],"symptoms.":[467],"Some":[468],"difficulty":[471,573],"re-engaging":[472],"services":[474,481],"clinicians":[476],"recognised":[477],"lack":[479],"adults.":[484],"continuing":[486],"considered":[489],"option":[493],"future,":[496],"but":[497],"concerned":[499],"about":[500],"process":[502],"impact":[507],"behaviour.":[509],"Conclusions:":[510],"demonstrated":[514],"GPs":[521],"dropped":[526],"significantly":[527],"15":[530],"21.":[532],"fall":[534],"greater":[538],"than":[539],"reported":[541],"age-related":[542],"decrease":[543],"symptoms,":[545],"raising":[546],"possibility":[548],"is":[551],"prematurely":[552],"discontinued":[553],"adults":[557,571],"where":[558],"symptoms":[560],"persist.":[561],"identified":[567],"obtaining":[575],"discharge":[578],"services.":[581],"Future":[582],"work":[583],"should":[584],"include":[585],"randomised":[586],"placebo-controlled":[587],"trials":[588],"into":[589],"long-term":[590],"stimulants,":[593],"particularly":[594],"methylphenidate.":[595],"\u00a9":[596],"2009":[597],"Queen's":[598],"Printer":[599],"Controller":[601],"HMSO.":[603],"All":[604],"rights":[605],"reserved.":[606]},"counts_by_year":[{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}